BOIRON SA (BOI.PA) Stock Fundamental Analysis
EPA:BOI - Euronext Paris - Matif - FR0000061129 - Common Stock - Currency: EUR
Taking everything into account, BOI scores 5 out of 10 in our fundamental rating. BOI was compared to 52 industry peers in the Pharmaceuticals industry. BOI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BOI has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
BOI had positive earnings in the past year.
BOI had a positive operating cash flow in the past year.
Each year in the past 5 years BOI has been profitable.
Each year in the past 5 years BOI had a positive operating cash flow.
1.2 Ratios
The Return On Assets of BOI (4.25%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 6.35%, BOI is in line with its industry, outperforming 48.08% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.87%, BOI is in line with its industry, outperforming 44.23% of the companies in the same industry.
BOI had an Average Return On Invested Capital over the past 3 years of 6.54%. This is significantly below the industry average of 12.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.25% | ||
| ROE | 6.35% | ||
| ROIC | 4.87% |
ROA(3y)5.14%
ROA(5y)4.82%
ROE(3y)7.49%
ROE(5y)7.13%
ROIC(3y)6.54%
ROIC(5y)6.48%
1.3 Margins
Looking at the Profit Margin, with a value of 4.92%, BOI is in line with its industry, outperforming 48.08% of the companies in the same industry.
BOI's Profit Margin has declined in the last couple of years.
The Operating Margin of BOI (6.10%) is comparable to the rest of the industry.
BOI's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 72.84%, BOI is doing good in the industry, outperforming 61.54% of the companies in the same industry.
BOI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.1% | ||
| PM (TTM) | 4.92% | ||
| GM | 72.84% |
OM growth 3Y4.86%
OM growth 5Y-13.35%
PM growth 3Y12.49%
PM growth 5Y-5.25%
GM growth 3Y-1.88%
GM growth 5Y-1.35%
2. Health
2.1 Basic Checks
BOI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BOI has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for BOI has been reduced compared to 5 years ago.
Compared to 1 year ago, BOI has an improved debt to assets ratio.
2.2 Solvency
BOI has an Altman-Z score of 3.47. This indicates that BOI is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BOI (3.47) is better than 61.54% of its industry peers.
BOI has a debt to FCF ratio of 0.60. This is a very positive value and a sign of high solvency as it would only need 0.60 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.60, BOI belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that BOI is not too dependend on debt financing.
BOI's Debt to Equity ratio of 0.02 is amongst the best of the industry. BOI outperforms 90.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.6 | ||
| Altman-Z | 3.47 |
ROIC/WACC0.62
WACC7.8%
2.3 Liquidity
BOI has a Current Ratio of 2.25. This indicates that BOI is financially healthy and has no problem in meeting its short term obligations.
BOI has a better Current ratio (2.25) than 76.92% of its industry peers.
BOI has a Quick Ratio of 1.37. This is a normal value and indicates that BOI is financially healthy and should not expect problems in meeting its short term obligations.
BOI's Quick ratio of 1.37 is fine compared to the rest of the industry. BOI outperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.25 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
The earnings per share for BOI have decreased strongly by -50.22% in the last year.
Measured over the past years, BOI shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.57% on average per year.
The Revenue has decreased by -6.89% in the past year.
The Revenue has been decreasing by -3.98% on average over the past years.
EPS 1Y (TTM)-50.22%
EPS 3Y11.29%
EPS 5Y-8.57%
EPS Q2Q%-78.46%
Revenue 1Y (TTM)-6.89%
Revenue growth 3Y-1.34%
Revenue growth 5Y-3.98%
Sales Q2Q%-4.81%
3.2 Future
The Earnings Per Share is expected to decrease by -3.01% on average over the next years.
BOI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.70% yearly.
EPS Next Y-13.55%
EPS Next 2Y-4.48%
EPS Next 3Y-3.01%
EPS Next 5YN/A
Revenue Next Year-2.5%
Revenue Next 2Y0.19%
Revenue Next 3Y0.13%
Revenue Next 5Y4.7%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 17.65, the valuation of BOI can be described as rather expensive.
65.38% of the companies in the same industry are more expensive than BOI, based on the Price/Earnings ratio.
BOI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.35.
A Price/Forward Earnings ratio of 10.38 indicates a reasonable valuation of BOI.
Based on the Price/Forward Earnings ratio, BOI is valued cheaper than 82.69% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BOI to the average of the S&P500 Index (22.10), we can say BOI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.65 | ||
| Fwd PE | 10.38 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BOI indicates a rather cheap valuation: BOI is cheaper than 88.46% of the companies listed in the same industry.
BOI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BOI is cheaper than 73.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.02 | ||
| EV/EBITDA | 6.92 |
4.3 Compensation for Growth
BOI's earnings are expected to decrease with -3.01% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.48%
EPS Next 3Y-3.01%
5. Dividend
5.1 Amount
BOI has a Yearly Dividend Yield of 5.47%, which is a nice return.
BOI's Dividend Yield is rather good when compared to the industry average which is at 2.88. BOI pays more dividend than 96.15% of the companies in the same industry.
BOI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.47% |
5.2 History
The dividend of BOI is nicely growing with an annual growth rate of 48.72%!
Dividend Growth(5Y)48.72%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
858.18% of the earnings are spent on dividend by BOI. This is not a sustainable payout ratio.
BOI's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP858.18%
EPS Next 2Y-4.48%
EPS Next 3Y-3.01%
EPA:BOI (3/7/2025, 7:00:00 PM)
24
-0.7 (-2.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners6.12%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap421.20M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.47% |
Yearly Dividend11.46
Dividend Growth(5Y)48.72%
DP858.18%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.65 | ||
| Fwd PE | 10.38 | ||
| P/S | 0.87 | ||
| P/FCF | 17.02 | ||
| P/OCF | 9.88 | ||
| P/B | 1.13 | ||
| P/tB | 1.66 | ||
| EV/EBITDA | 6.92 |
EPS(TTM)1.36
EY5.67%
EPS(NY)2.31
Fwd EY9.64%
FCF(TTM)1.41
FCFY5.87%
OCF(TTM)2.43
OCFY10.12%
SpS27.45
BVpS21.25
TBVpS14.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.25% | ||
| ROE | 6.35% | ||
| ROCE | 6.62% | ||
| ROIC | 4.87% | ||
| ROICexc | 5.63% | ||
| ROICexgc | 8.17% | ||
| OM | 6.1% | ||
| PM (TTM) | 4.92% | ||
| GM | 72.84% | ||
| FCFM | 5.14% |
ROA(3y)5.14%
ROA(5y)4.82%
ROE(3y)7.49%
ROE(5y)7.13%
ROIC(3y)6.54%
ROIC(5y)6.48%
ROICexc(3y)10.05%
ROICexc(5y)10.04%
ROICexgc(3y)14.99%
ROICexgc(5y)14.74%
ROCE(3y)8.91%
ROCE(5y)8.81%
ROICexcg growth 3Y0.78%
ROICexcg growth 5Y-16.74%
ROICexc growth 3Y1.62%
ROICexc growth 5Y-16.92%
OM growth 3Y4.86%
OM growth 5Y-13.35%
PM growth 3Y12.49%
PM growth 5Y-5.25%
GM growth 3Y-1.88%
GM growth 5Y-1.35%
F-Score5
Asset Turnover0.86
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.6 | ||
| Debt/EBITDA | 0.15 | ||
| Cap/Depr | 73.99% | ||
| Cap/Sales | 3.71% | ||
| Interest Coverage | 24.05 | ||
| Cash Conversion | 79.6% | ||
| Profit Quality | 104.45% | ||
| Current Ratio | 2.25 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 3.47 |
F-Score5
WACC7.8%
ROIC/WACC0.62
Cap/Depr(3y)97%
Cap/Depr(5y)83.85%
Cap/Sales(3y)3.87%
Cap/Sales(5y)4.48%
Profit Quality(3y)70.53%
Profit Quality(5y)85.18%
High Growth Momentum
Growth
EPS 1Y (TTM)-50.22%
EPS 3Y11.29%
EPS 5Y-8.57%
EPS Q2Q%-78.46%
EPS Next Y-13.55%
EPS Next 2Y-4.48%
EPS Next 3Y-3.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.89%
Revenue growth 3Y-1.34%
Revenue growth 5Y-3.98%
Sales Q2Q%-4.81%
Revenue Next Year-2.5%
Revenue Next 2Y0.19%
Revenue Next 3Y0.13%
Revenue Next 5Y4.7%
EBIT growth 1Y-52.02%
EBIT growth 3Y3.46%
EBIT growth 5Y-16.79%
EBIT Next Year22.81%
EBIT Next 3Y13.34%
EBIT Next 5YN/A
FCF growth 1Y-48.55%
FCF growth 3Y-16.73%
FCF growth 5Y-5.56%
OCF growth 1Y-37.95%
OCF growth 3Y-12.66%
OCF growth 5Y-11.6%